Oxcarbazepine
- Product NDC
- 70518-3127
- 11-digit product format
- 705183127
- Labeler code
- 70518
- Product ID
- 70518-3127_ef17b4bf-f20e-4a6d-e053-2a95a90ae494
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Oxcarbazepine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA077802
- Marketing category
- ANDA
- Marketing start
- 2021-06-17
- Marketing end
- 0000-00-00
- Substance
- OXCARBAZEPINE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-3127-0 | 70518312700 | 100 POUCH in 1 BOX (70518-3127-0) > 1 TABLET, FILM COATED in 1 POUCH (70518-3127-1) | 100 pouch | 2021-06-17 | 0000-00-00 | No | No | Current |
| 70518-3127-2 | 70518312702 | 30 TABLET, FILM COATED in 1 BLISTER PACK (70518-3127-2) | | 2022-12-05 | 0000-00-00 | No | No | Current |